文献速递肿瘤 PET/CT

肿瘤内代谢异质性与定量18F-FDG PET/CT参数对HPV阳性原发性口咽鳞状细胞癌患者预后预测的价值

Value of Intratumoral Metabolic Heterogeneity and Quantitative 18F-FDG PET/CT Parameters to Predict Prognosis in Patients With HPV-Positive Primary Oropharyngeal Squamous Cell Carcinoma.
PubMed 文献 · Clin Nucl Med · 2017-01-01

该回顾性研究纳入105例HPV阳性原发性口咽鳞状细胞癌患者,评估肿瘤内代谢异质性(AUC-CSH)及SUVmax、MTV等定量FDG PET/CT参数对无事件生存期(EFS)的预测价值。中位随访35.4个月,19例复发、11例死亡。多因素分析显示AUC-CSH指数与EFS相关,SUVmax和MTV的最佳截断值可显著预测EFS,高异质性合并高SUVmax或高MTV者预后更差。

要点

  • AUC-CSH指数(PET梯度法P=0.034,50%阈值法P=0.02)是多因素分析中EFS的独立预后因素。
  • SUVmax最佳截断值16.7、总MTV最佳截断值12.7 mL可显著预测EFS。
  • 高肿瘤内异质性合并高SUVmax(log-rank P=0.026)或高MTV(log-rank P=0.022)者预后更差。

核心结论

  • FDG PET测得的肿瘤内代谢异质性是HPV阳性原发性口咽鳞状细胞癌患者EFS的预后因素。
  • FDG亲和力、代谢肿瘤负荷与肿瘤内异质性的联合预测效应可提供该人群的预后生存信息。

研究设计与样本

  • 回顾性研究,纳入105例HPV阳性原发性口咽鳞状细胞癌患者。
  • 测量原发肿瘤及可获取的转移灶的SUVmax和代谢肿瘤体积(MTV),计算原发肿瘤AUC-CSH作为肿瘤内代谢异质性指标。
  • 中位随访35.4个月(范围3-92个月),终点为无事件生存期(EFS),采用Kaplan-Meier生存曲线和Cox回归分析。

主要发现

  • 105例中研究期间19例复发、11例死亡。
  • 多因素分析显示AUC-CSH指数与EFS相关:PET梯度法P=0.034,50%阈值法P=0.02。
  • Kaplan-Meier生存分析显示SUVmax最佳截断值16.7和总MTV最佳截断值12.7 mL均为EFS的显著预测因素。
  • 按SUVmax和AUC-CSH指数分为3个亚组,肿瘤内异质性较高且SUVmax较高者预后更差(log-rank P=0.026)。
  • 肿瘤内异质性较高且MTV较高者预后更差(log-rank P=0.022)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to evaluate the impact of intratumoral metabolic heterogeneity and quantitative FDG PET/CT imaging parameters for predicting patient outcomes in primary oropharyngeal squamous cell cancer (OPSCC). PATIENTS AND METHODS: We retrospectively investigated 105 patients with HPV-positive OPSCC. SUVmax and metabolic tumor volume (MTV) were measured for the primary tumors and when available for the metastatic sites. Primary tumor intratumoral metabolic heterogeneity was calculated as the area under a cumulative SUV volume histograms curve (AUC-CSH). The median follow-up time was 35.4 months (range, 3-92 months). Outcome end point was event-free survival (EFS). Kaplan-Meier survival plots and Cox regression analyses were performed. RESULTS: Of the 105 patients included, 19 patients relapsed and 11 deceased during the study period. AUC-CSH indexes were associated with EFS using PET gradient-based (P = 0.034) and 50% threshold (P = 0.02) segmentation methods, on multivariate analysis. Kaplan-Meier survival analysis using optimum cutoff of 16.7 SUVmax and 12.7 mL total MTV were significant predictors of EFS. Combining SUVmax and AUC-CSH index in 3 subgroups, patients with higher intratumoral heterogeneity and higher SUVmax were associated with worse outcome (log-rank, P = 0.026). Similarly, patients with higher intratumoral heterogeneity tumors and higher MTV had worse prognosis (log-rank, P = 0.022). CONCLUSIONS: Intratumoral metabolic heterogeneity using FDG PET was a prognostic factor for EFS in patients with primary HPV (+) OPSCC. The combined predictive effect of FDG avidity, metabolic tumor burden, and intratumoral heterogeneity provided prognostic survival information in these patients.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Mena E, Taghipour M, Sheikhbahaei S, et al. Value of Intratumoral Metabolic Heterogeneity and Quantitative 18F-FDG PET/CT Parameters to Predict Prognosis in Patients With HPV-Positive Primary Oropharyngeal Squamous Cell Carcinoma. Clin Nucl Med. 2017. PMID: 28195905. doi:10.1097/RLU.0000000000001578

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。